Sarah Wordsworth, PhD
Cited by
Cited by
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial
U Chakravarthy, SP Harding, CA Rogers, SM Downes, AJ Lotery, ...
Ophthalmology 119 (7), 1399-1411, 2012
Liberal or restrictive transfusion after cardiac surgery
GJ Murphy, K Pike, CA Rogers, S Wordsworth, EA Stokes, GD Angelini, ...
New England Journal of Medicine 372 (11), 997-1008, 2015
Applied methods of cost-effectiveness analysis in healthcare
AM Gray, PM Clarke, JL Wolstenholme, S Wordsworth
Oxford University Press, 2011
Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study
LJ Pankhurst, C del Ojo Elias, AA Votintseva, TM Walker, K Cole, J Davies, ...
The Lancet Respiratory Medicine 4 (1), 49-58, 2016
Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature
K Schwarze, J Buchanan, JC Taylor, S Wordsworth
Genetics in Medicine 20 (10), 1122-1130, 2018
Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial
S Bhattacharya, K Harrild, J Mollison, S Wordsworth, C Tay, A Harrold, ...
Bmj 337, 2008
Effect of a strategy of a supraglottic airway device vs tracheal intubation during out-of-hospital cardiac arrest on functional outcome: the AIRWAYS-2 randomized clinical trial
JR Benger, K Kirby, S Black, SJ Brett, M Clout, MJ Lazaroo, JP Nolan, ...
Jama 320 (8), 779-791, 2018
DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
S Wordsworth, J Leal, E Blair, R Legood, K Thomson, A Seller, J Taylor, ...
European heart journal 31 (8), 926-935, 2010
Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis
SD Grosse, S Wordsworth, K Payne
Genetics in Medicine 10 (9), 648-654, 2008
Collecting unit cost data in multicentre studies
S Wordsworth, A Ludbrook, F Caskey, A Macleod
The European Journal of Health Economics 6 (1), 38-44, 2005
Sensitivity of willingness to pay estimates to the level of attributes in discrete choice experiments
M Ryan, S Wordsworth
Scottish Journal of Political Economy 47 (5), 504-524, 2000
Early referral and planned initiation of dialysis: what impact on quality of life?
FJ Caskey, S Wordsworth, T Ben, FT de Charro, C Delcroix, ...
Nephrology Dialysis Transplantation 18 (7), 1330-1338, 2003
Issues surrounding the health economic evaluation of genomic technologies
J Buchanan, S Wordsworth, A Schuh
Pharmacogenomics 14 (15), 1833-1847, 2013
The challenge of antimicrobial resistance: what economics can contribute
LSJ Roope, RD Smith, KB Pouwels, J Buchanan, L Abel, P Eibich, ...
Science 364 (6435), 2019
Indirect comparisons of treatments based on systematic reviews of randomised controlled trials
SJ Edwards, MJ Clarke, S Wordsworth, J Borrill
International journal of clinical practice 63 (6), 841-854, 2009
Eliciting expert opinion for economic models: an applied example
J Leal, S Wordsworth, R Legood, E Blair
Value in Health 10 (3), 195-203, 2007
Cost‐minimisation analysis versus cost‐effectiveness analysis, revisited
H Dakin, S Wordsworth
Health economics 22 (1), 22-34, 2013
Preferences for general practice jobs: a survey of principals and sessional GPs
S Wordsworth, D Skåtun, A Scott, F French
British Journal of General Practice 54 (507), 740-746, 2004
Ultrasound scanning by general practitioners: is it worthwhile?
S Wordsworth, A Scott
Journal of Public Health 24 (2), 88-94, 2002
Hemodialysis for end-stage renal disease: A cost-effectiveness analysis of treatment options
JG Gonzalez-Perez, L Vale, SC Stearns, S Wordsworth
International Journal of Technology Assessment in Health Care 21 (1), 32, 2005
The system can't perform the operation now. Try again later.
Articles 1–20